SEC Tracker
Get the app

Traws Pharma TRAW

Traws Pharma proposes reverse stock split

Additional proxy materials

Form
DEFA14A
Filed
Importance
Routine
  1. Proposed reverse stock split ratio 1-for-8 to 1-for-15
  2. Board to determine ratio within 12 months
  3. Meeting date December 3, 2026

Written from the DEFA14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Traws Pharma files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Mannatech MTEX public float $10M, Jun 30, 2025
  2. LeonaBio ATHA public float $10M, Jun 30, 2025
  3. BioCardia BCDA public float $10M, Jun 30, 2025
  4. Alaunos Therapeutics TCRT public float $10M, Jun 30, 2025
  5. Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025